Evidence map›Paper›PMID 24182854›Full record

ReviewRheumatic diseases clinics of North America2013

Update on juvenile spondyloarthritis.

Anusha Ramanathan, Hemalatha Srinivasalu, Robert A Colbert

Abstract readReview
In one paragraph

Review in Rheumatic diseases clinics of North America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Enthesitis-related arthritis: current perspectives.Open access rheumatology : research and reviews · 2019
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Enthesitis-related arthritis.Clinical rheumatology · 2015
    Review
  18. Juvenile spondyloarthritis.Current opinion in rheumatology · 2015
    Review
  19. Enthesitis-related arthritis: time to re-define?Current rheumatology reports · 2014
    Article
  20. Treatment of juvenile idiopathic arthritis: a revolution in care.Pediatric rheumatology online journal · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anusha RamanathanDivision of Rheumatology, Keck School of Medicine of USC, Children's Hospital of Los Angeles, 4650 Sunset Boulevard, MS#60, Los Angeles, CA 90027, USA.
Hemalatha Srinivasalu
Robert A Colbert

Funding

Pathogenic Mechanisms in SpondyloarthritisZIAAR041184 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI COLBERT, ROBERT · 2009 to 2025
$47.6M
Intramural NIH HHS ZIA AR041184NIAMS NIH HHS Z01 AR041184
6 · The paper itself

Abstract

Spondyloarthritis (SpA) encompasses a group of disorders linked by overlapping clinical manifestations and genetic predisposition. Newer classification systems developed for adults with SpA focus on identifying individuals with axial or predominantly peripheral involvement. All forms of SpA can begin during childhood, and can be considered on a continuum with adult disease. Nevertheless, there are important differences in presentation and outcome that depend on age at onset. This article highlights these differences, what has been learned about genetics and pathogenesis of SpA, and important unmet needs for future studies.

Indexed as

AdolescentAntirheumatic AgentsArthritis, PsoriaticArthritis, ReactiveChildHumansInflammatory Bowel DiseasesSacroiliitisSpondylarthropathiesSpondylitis, AnkylosingAntirheumatic AgentsAxial spondyloarthritisEnthesitis-related arthritisHLA-B27Juvenile psoriatic arthritisJuvenile spondyloarthritis

Identifiers

PMID24182854
PMCPMC3932443

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.